The Freud-1/CC2D1A Family: Multifunctional Regulators Implicated in Mental Retardation by Anne M. Millar et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






The Freud-1/CC2D1A Family: Multifunctional 
Regulators Implicated in Mental Retardation 
Anne M. Millar, Tatiana Souslova and Paul R. Albert 
Ottawa Hospital Research Institute (Neuroscience), 
Department of Cellular and Molecular Medicine, University of Ottawa, Ontario,  
Canada 
1. Introduction  
1.1 Mental retardation  
Mental retardation is classified by the DSM-IV-TR as a developmental disorder, with 
diagnosis contingent upon the presence of three cardinal features: below average cognitive 
function (IQ≤70); significant deficits in multiple adaptive skill domains, and; onset prior to 
eighteen years of age (American Psychiatric Association. & American Psychiatric 
Association. Task Force on DSM-IV., 2000). The prevalence of MR, while difficult to 
ascertain, is often cited as affecting 1-3% of the population (Chechlacz & Gleeson, 2003; 
Leonard & Wen, 2002; McDermott, et al., 2007). Complicating an understanding of the 
disorder is the fact that a spectrum of phenotypes are subsumed under the term mental 
retardation, which can manifest as a variety of syndromes with differing degrees of 
impairment. Genetic and chromosomal abnormalities as well as environmental factors 
(infections, malnutrition, trauma, toxins, etc.) have been implicated as playing a causal role 
in the development of MR, however idiopathic MR is the single most common origin, 
accounting for 30-50% of cases (McDermott, et al., 2007). The diversity of MR in terms of 
presentation and etiology reflects the heterogeneity of the disorder and has confounded a 
complete understanding of its pathophysiology. It is clear that MR causes substantial 
impairment, thus the need exists to clarify and characterize factors contributing to the 
disrupted developmental processes that result in MR. In an attempt to understand the 
underlying developmental mechanisms affected in MR, this chapter will examine one 
variant of MR, non-syndromic mental retardation (NSMR). In particular, the potential 
contribution of one gene/protein product, CC2D1A, will be explored in the development of 
NSMR.  
1.2 Non-syndromic mental retardation 
NSMR is the term applied to those developmental disorders meeting the diagnostic 
criteria for MR in the absence of any other abnormalities or deficits and accounts for 30-
40% of MR diagnoses. Of those cases with a known genetic cause, both X-linked and 
autosomal inheritance patterns have been observed in NSMR (Basel-Vanagaite, et al., 
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2003). However, the limited study of NSMR has resulted in a mere eight genes being 
identified in the etiology of autosomal recessive NSMR. These include PRSS12, encoding a 
neuronal serine protease (Molinari, et al., 2002), CRBN, encoding a ATP-dependent Lon 
protease (Higgins, et al., 2004), GRIK2, encoding the ionotropic glutamate receptor 6 
(Motazacker, et al., 2007), TECR, a synaptic glycoprotein (Caliskan, et al., 2011), TUSC3, 
an oligosaccharyltransferase required for N-glycosylation (Garshasbi, et al., 2008; Khan, et 
al., 2011; Molinari, et al., 2008), TRAPPC9, a neuronal protein trafficking complex 
involved in NF-KB activation (Mir, et al., 2009; Mochida, et al., 2009), SOBP, a nuclear zinc 
finger protein (Birk, et al., 2010) and CC2D1A (Basel-Vanagaite, et al., 2006). The latter, 
CC2D1A, located in chromosomal region 19p13.12-13.2, has been identified as a locus for 
autosomal recessive NSMR (Basel-Vanagaite, et al., 2003). Within this region, a mutation 
in the coiled coil and C2 domain containing 1A (CC2D1A) gene generates a truncated 
protein product, with affected individuals being homozygous for this mutant protein 
(Basel-Vanagaite, et al., 2003; Basel-Vanagaite, et al., 2006). The mutation related to NSMR 
is a 3.6 kb deletion in the ~900kb gene region which produces a frame shift, creating a 
premature stop codon and resulting in a truncated protein which lacks a number of 
potentially functional domains, including a single DM14 domain, a HLH domain and a C2 
domain (Ou, et al., 2003). It is feasible that the remaining domains in this truncation 
mutant, the three DM14 domains, may allow the protein to retain some function. In 
support of this, a recent report found that in mice, CC2D1A knockout is lethal (shortly 
after birth) due to respiratory failure, however no gross anatomical changes were evident 
(Zhao, et al., 2011). This study also found abnormal EPSC and IPSC amplitudes in cortical 
neurons harvested from the knockout animals, implicating CC2D1A in synapse 
maturation. Overexpression of CC2D1A following embryonic development partially 
rescued this phenotype. These data suggest that either the truncation mutant present in 
NSMR retains some function to support non-lethality in humans or that the mouse is 
more sensitive to the loss of CC2D1A. Given the 82% amino acid sequence identity 
between mouse and human CC2D1A, the former is perhaps more plausible, however, this 
has yet to be explored fully.   
1.3 CC2D1A 
Human CC2D1A belongs to a gene family consisting of two homologous genes: CC2D1A 
and CC2D1B, which share critical domains (indicated below) with 40.8% amino acid identity 
(Hadjighasem et al. 2009) and are conserved across the animal kingdom. Another protein, 
CC2D2A, with domain (but not sequence) similarity has also been identified and is 
associated with mental retardation (Noor, et al., 2008). CC2D1A has also been termed Freud-
1, Aki1 and TAPE in the literature depending on its function. Sequence alignments indicate 
substantial sequence identity with mouse and C. elegans orthologues, and also with the 
single D. melanogaster orthologue, lethal giant discs (Lgd) (Albert & Lemonde, 2004; Basel-
Vanagaite, et al., 2006). Structurally, full length CC2D1A protein and its orthologues consist 
of a helix-loop-helix (HLH) domain, a calcium-dependent C2 phospholipid binding domain 
(protein kinase C conserved region 2), a proline rich domain (Williamson, 1994), coiled coil 
motifs (Burkhard, et al., 2001) and four Drosophila melanogaster-14 (DM-14) domains of 
unknown function (Basel-Vanagaite, et al., 2003; Basel-Vanagaite, et al., 2006; Ou, et al., 
2003) [Figure 1].  
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Fig. 1. Schematic of human CC2D1A protein.  
Both full length and the NSMR truncation are shown, with C2 (purple), HLH (yellow), DM-
14 domains (green), coiled coil (open boxes) and proline rich (shaded box) regions indicated. 
The black box represents the sequence of 30 nonsense amino acids in the NSMR protein. 
Long and short isoforms have been identified, with the short form lacking the first two 
DM14 domains. Both are functional, however, in humans, the long isoform predominates, 
while in rodents the short isoform appears to be the most common (Rogaeva & Albert, 
2007).  
Our lab has identified widespread expression of CC2D1A in rodent brains by Northern blot 
analysis and in situ hybridization, with mRNA levels being highest in the cortex, 
hippocampus, raphe nuclei and substantia nigra (Ou, et al., 2003). Furthermore, CC2D1A 
mRNA expression has been observed in the murine brain from E12 to adulthood (Basel-
Vanagaite, et al., 2006). Together, these findings allude to potential roles of CC2D1A 
throughout development and maturity in the rodent brain. Consistent with this distribution 
in the rodent, our lab has also confirmed similar tissue localization patterns in the human, 
again with Northern blot analysis indicating CC2D1A mRNA presence in the cortex, 
amygdala, hippocampus, thalamus (Rogaeva & Albert, 2007). The extensive distribution of 
the protein spatially and its involvement in NSMR is suggestive of widespread activity both 
developmentally and in adult humans also. 
Recent evidence suggests that CC2D1A, in addition to its relationship with NSMR, has an 
array of functions in animal models, with specific domains potentially accounting for these 
functions, although these are still relatively uncharacterized. They include the contribution 
of CC2D1A to regulating transcription, as well as Notch, Akt and NF-κB signaling and will 
be discussed in detail below (Figure 2). The dual transcription and signalling roles of 
CC2D1A imply its presence in both the nucleus and the cytoplasm, as we have shown in 
several human and rodent cell lines by biochemical fractionation (Rogaeva & Albert, 2007), 
and in neurons by immunofluorescence (Ou, et al., 2003). However the extent of nuclear 
localization appears to be cell type dependent as a recent report found predominantly 
cytoplasmic localization of CC2D1A in HEK293 cells (Zhao, et al., 2010). Nonetheless, these 
data agree with the proposed cytoplasmic and nuclear regulatory roles and suggest 
regulation of its nuclear export (Rogaeva & Albert, 2007). As well as transcriptional 
regulatory function, each of the signaling pathways mentioned has been implicated in 
regulating developmental processes, thus it is proposed that at least some of these pathways 
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under the control of CC2D1A are disrupted when CC2D1A is compromised, affecting 
normative neuronal development. It is likely that a consequence of dysregulation of one or 
more of these systems may be the induction of developmental abnormalities that lead to 
MR.  
2. CC2D1A-mediated regulation of gene expression 
Initial identification of CC2D1A function using a screen for NF-kB activators suggested a 
limited role as an NF-kB signalling activation compared to other activators (Matsuda, et al., 
2003). Subsequently, a yeast one-hybrid screen done in our lab identified the protein as a 
transcriptional repressor of the serotonin 1A (5-HT1A) receptor gene (Ou, et al., 2000; Ou, et 
al., 2003; Rogaeva & Albert, 2007). The 5-HT1A receptor has been identified as an inhibitory 
G-protein coupled receptor, coupling specifically to Gi/Go proteins, resulting in decreased 
adenylyl cyclase activity, activation of potassium channels, and inhibition of calcium 
channels (Barnes & Sharp, 1999; Lanfumey & Hamon, 2004). The 5-HT1A receptor is 
expressed as both a somatodendritic autoreceptor on serotonin neurons in the raphe nuclei, 
and as heteroreceptors on serotonin targets including interneurons and pyramidal cells of 
the PFC and hippocampus and neurons of the hypothalamus, amygdala and septum 
(Aznar, et al., 2003; Varnas, et al., 2004). By hyperpolarizing the membrane potential, 5-
HT1A autoreceptor activation decreases both firing activity and 5-HT release, acting as a 
negative feedback circuit allowing serotonergic raphe neurons modulate their own activity 
in addition to the activity of neurons upon which they synapse. The 5-HT system, which 
originates in the raphe nuclei and projects broadly to the PFC, hippocampus, hypothalamus, 
amygdala and septum (Barnes & Sharp, 1999), has been implicated in diverse functions, 
ranging from affect, pain, mood, stress response, sleep, aggression to appetite (Pucadyil, et 
al., 2005; Zhuang, et al., 1999). The preponderance of evidence regarding the developmental 
requirement of the 5-HT1A receptor has focused on its relationship to anxiety and 
depression. Initially, 5-HT1A receptor knockout studies identified increased anxiety- and 
decreased depression-like phenotypes in rodents (Heisler, et al., 1998; Parks, et al., 1998; 
Ramboz, et al., 1998), which could be rescued with early life postnatal overexpression 
(Gross, et al., 2002). Subsequent work indicated that suppression of 5-HT1A autoreceptors 
(but not heteroreceptors) throughout life increased anxiety-like responses, while 
developmental knockout of the heteroreceptors did increase depressive-like behaviours 
(Richardson-Jones, et al., 2010). The authors suggest increased developmental 5-HT neuron 
excitability as a plausible causative factor in the generation of anxiety phenotypes. These 
findings certainly point to the need for appropriate developmental regulation of 5-HT1A 
receptor expression in ensuring normative function in the adult. More pertinent to the 
discussion of NSMR is the finding that 5-HT1A receptor function has been linked to 
cognition. Atypical antipsychotics that are 5-HT1A receptor partial agonists improved 
cognitive function in the adult rodent (Schechter, et al., 2005; Sumiyoshi & Meltzer, 2004). 
Conversely, knockout of the receptor results in impaired cognitive function (Sarnyai, et al., 
2000), suggesting that impaired 5-HT1A activity during development may negatively 
impact later cognitive processes. Furthermore, the receptor is induced at later times during 
synaptic development to inhibit neuronal excitability of the prefrontal cortex (Beique, et al., 
2004). Together these findings implicate the developmental importance of the 5-HT1A 
receptor in temporally and spatially appropriate sculpting of cortical circuitry and activity, 
which if disturbed may have repercussions leading to MR.  
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Our lab demonstrated, via mutational analysis of the region upstream of the 5-HT1A 
transcription start site, the presence of a dual repressor element (DRE) which, when absent 
resulted in strongly enhanced 5-HT1A expression as evidenced by transcriptional reporter 
assays (Ou, et al., 2000). Subsequently, we used yeast one hybrid to identify CC2D1A as the 
regulatory protein responsible for 5-HT1A repression (Ou, et al., 2003). CC2D1A, also 
known as Freud-1 (five prime repressor under dual repression binding protein-1) was 
identified, and shown by electrophoretic mobility shift assay (EMSA) to bind the dual 
repressor element (DRE) (Ou, et al., 2003; Rogaeva & Albert, 2007). The 31-base pair DRE is 
comprised of a 5’- and a 3’- repressor element and is highly conserved across rat, mouse, 
and human genes (Albert & Lemonde, 2004). Upon binding to the DRE, CC2D1A repressed 
5-HT1A receptor expression 10-fold in vitro, while mutation of the repressor element or 
increase in calcium levels abrogated these effects (Ou, et al., 2003; Rogaeva & Albert, 2007), 
consistent with a role in regulation of gene expression. In order to elucidate the domains 
within CC2D1A required for binding to the DRE and repression, our lab is currently 
engaged in functional domain analysis, deleting key domains to explore their function. 
Preliminary work indicates that the NSMR-like mutant is incapable of binding the 5-HT1A 
DRE as seen with EMSA, nor is this mutant able to repress 5-HT1A expression in reporter 
assays (Millar, et al., 2011).  
Similarly, our lab has shown, using EMSA and chromatin immunoprecipitation that 
CC2D1A binds a region homologous to the 5-HT1A-DRE in the dopamine D2 receptor 
promoter (D2-DRE), and demonstrated its repression of the D2 receptor using reporter 
assays (Rogaeva, et al., 2007). It is possible that CC2D1A-mediated dysregulation of 5-HT1A 
and D2 receptors may contribute to the developmental abnormalities seen in NSMR. 
However it is our contention that further genes will be identified as targets for modulation 
by CC2D1A and it is perhaps more likely that some of these other genes would be critical 
developmental regulators. Thus it is a current goal of our lab to identify other genes under 
the transcriptional control of CC2D1A and to examine the contribution of these genes to 
developmental regulation.  
3. CC2D1A and Notch signaling 
Notch signaling is a cell-cell signaling pathway found in and highly conserved across the 
animal kingdom. It has been shown to be involved in developmental regulation and in stem 
cell maintenance in an array of tissues, including the brain where it ensures normal 
neuronal structure and function (Lai, 2004). Of note, recent case studies have identified 
deletions within the 19p13.12-13.2 region (the same region containing CC2D1A), resulting in 
the loss of Notch3, as putatively causative factors in the development of syndromic MR 
(Engels, et al., 2007; Jensen, et al., 2009; Van der Aa, et al., 2010), thus this region may be 
particularly relevant to maintaining or directing the formation of developmentally accurate 
and functional neurocircuitry.  
In mammals, the effectors in this signaling cascade are a family of four transmembrane 
receptors (NOTCH1-4) and associated ligands including Delta (Dll1, 3, 4) and Jagged (Jag1 
and 2). The presence of multiple receptor and ligand types implies the ability to respond to a 
broad array of signals and in turn to differentially respond depending on the context. The 
Notch receptor is a large single-pass transmembrane receptor which upon ligand binding, is 
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sequentially cleaved, triggering the Notch signaling cascade. The S2 cleavage event is 
catalyzed by the protease ADAM and cuts the extracellular segment (Brou, et al., 2000; 
Lieber, et al., 2002), permitting a subsequent cleavage event, which is mediated by a 
presenilin-dependent γ-secretase (De Strooper, et al., 1999; Struhl & Greenwald, 1999). This 
S3 cleavage frees the Notch intracellular domain, which can then translocate to the nucleus 
where it interacts with the transcription factor CSL/Mastermind (Mam) to exert its effects 
on downstream target genes (among which is the HES family of developmentally relevant 
genes has been well studied).  
Proper development demands an ordered process by which to establish and maintain 
correct pattern formation and differentiation. Both developmentally and in stem cell 
maintenance, Notch meets this demand via three distinct mechanisms: lateral inhibition, 
lineage decisions, and boundary formation/maintenance (as reviewed by Bray 2006)). With 
respect to lateral inhibition, Notch appears to magnify small differences in a population of 
cells, thereby determining cell fate (e.g., Notch regulates the number of cells that acquire 
neural potential). Lineage decisions refer to the finding that Notch determines whether 
progeny determined by lateral inhibition will differentiate into one cell type of another (e.g., 
neural or glial). This is accomplished by asymmetrical inheritance of Notch regulators 
which, in some cases or tissues, inhibits neural differentiation and in others promotes it. 
Boundary specification is critical in development and Notch signaling between two cell 
populations can define a boundary to organize/segregate the two groups. Dysregulation at 
any stage in this process could impair developmental processes necessary for normal 
neuronal structure and function. 
Regulation of Notch activity is achieved in part by the spatial and temporal localization of 
Notch ligands, but in addition, its activity is tightly controlled by a number of other 
mechanisms, including endocytosis and ubiquitylation. Endocytosis was established as 
critical to Notch signaling by genetic studies in D. melanogaster (Parks, et al., 2000; Seugnet, 
et al., 1997).  As Notch is a cell-surface receptor, its localization is at the plasma membrane, 
however, it is also found cytoplasmically, specifically within endocytic compartments. In D. 
melanogaster, Notch colocalizes with endosomal markers and when the endocytic cycle is 
perturbed, intracellular accumulation of Notch occurs (Jekely & Rorth, 2003; Wilkin, et al., 
2004). When sorting of ubiquitin-tagged membrane proteins (e.g., Endosomal Sorting 
Complex Required for Transport [ESCRT]) is disrupted, over-activation of the Notch 
pathway results. However, mutation of a number of endocytic components leads to 
increased Notch protein levels without affecting Notch function (Moberg, et al., 2005; 
Thompson, et al., 2005; Vaccari & Bilder, 2005). In addition to endocytic control mechanisms, 
E3 ubiquitin ligases (e.g., Neuralized, Mindbomb) interact with Notch ligands and are 
required for Notch activation (Chitnis, 2006; Le Borgne, et al., 2005). The absence of the E3 
ubiquitin ligases, Neuralized or Mindbomb, leads to abnormalities in Notch ligand 
trafficking resulting in ligand accumulation on the cell surface, although these accumulated 
ligands are inactive (Wang & Struhl, 2005). These findings support a link between regulation 
of ligand activity by E3 ubiquitin ligases and endocytosis within the Notch pathway. Thus it 
is possible that disruption of these mechanisms could have relevance in development and 
by extension in NSMR. 
Given the sequence identity and the domains shared between human CC2D1A and its D. 
melanogaster orthologue, lethal (2) giant discs (Lgd), it is of interest that the latter has been 
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implicated in the regulation of Notch signalling. Lgd, a known tumour suppressor, 
modulates the Notch pathway by binding phospholipids on early endosomes and targeting 
Notch for trafficking to the degradative pathway (Childress, et al., 2006; Gallagher & 
Knoblich, 2006; Jaekel & Klein, 2006; Klein, 2003). In the endosomal pathway, ubiquitylated 
proteins are recognized by Hrs, a ubiquitin binding protein targeted to early endosomes. 
Hrs binds the ESCRTI complex which activates ESCRTII leading to ESCRTIII recruitment, to 
budding of vesicles into the endosome and to multivesicular body (MVB) formation 
(Raiborg & Stenmark, 2009). Following fusion with lysosomes, the MBVs and their contents 
are degraded. In addition to involvement with MBVs, ESCRT proteins function in other 
fission events including the abscission stage in cytokinesis (Carlton, et al., 2008; Lindas, et 
al., 2008; Morita, et al., 2007; Samson, et al., 2008) and enveloped virus budding (Bieniasz, 
2009). Mutations in Lgd result in abnormal accumulation of Notch and other 
transmembrane proteins (e.g., Delta and EGF receptor) within the early endosome 
(Gallagher & Knoblich, 2006). This phenotype mimicked that seen with mutant ESCRT 
proteins which are essential for protein sorting to the degradative pathway (Moberg, et al., 
2005; Thompson, et al., 2005; Vaccari & Bilder, 2005). While it is undefined exactly why this 
protein trafficking deficit would lead to increased Notch activity, it is suggested that the 
most probable reason relates to the location of the final Notch cleavage event that leads to 
Notch activation (Gallagher & Knoblich, 2006). Although it is unknown where this cleavage 
occurs, it has been shown that the cleavage enzyme presenilin localizes to and is active both 
at the plasma membrane and at endosomal membranes. Since the presenilin-mediated 
cleavage is required for Notch activation and lgd normally targets Notch to the endosome 
where it accumulates, it is postulated that Notch may be cleaved and activated by the 
protease within the endosome (Klein, 2003). This is consistent with evidence demonstrating 
that with lgd mutations, ectopic Notch signaling is ligand independent (Jaekel & Klein, 
2006). Together, these findings in D. melanogaster implicate a developmental role for Lgd in 
mediating endocytic control of Notch function. 
Lgd bound to the monophosphorylated phosphatidyl inositides PI(3)P, PI(4)P and PI(5)P in 
vitro (Gallagher & Knoblich, 2006), which is of interest given that the two former lipids have 
been shown to associate respectively with early endosomes and secretory vesicles (Czech, 
2003). Deletion of the C-terminal region of Lgd, containing the phospholipid binding C2 
domain, precluded binding to phospholipids, while a point mutation in the fourth DM14 
domain generated a mutant phenotype reminiscent of that seen when Notch activity is 
dysregulated (Gallagher & Knoblich, 2006), although it remains to be characterized whether 
mutating the fourth DM14 domain actually does disrupt Notch activity. With respect to 
developmental processes, normal pattern formation and differentiation in D. melanogaster 
wing development have been shown to depend on Notch activation (Klein, 2001). 
Throughout much of wing development, Notch activity is limited to the dorsoventral 
boundary, a function that is abrogated in lgd mutants (Klein, 2003). Furthermore, 
appropriate Notch activity is also a prerequisite for correct gene expression at this boundary 
(Klein, 2003). Disruption of lgd leads to ectopic activation of Notch signaling during wing 
development and sensory organ precursor cell selection (Klein, 2003). Further study 
identified the requirement of lgd in all imaginal disc cells to repress Notch activity (Jaekel & 
Klein, 2006). It remains unclear exactly how or even whether Notch interacts directly with 
lgd, however it appears that lgd exerts its effects between the early endosomal ubiquitin 
binding protein, Hrs, and the late endosomal component, Vps25 (Childress, et al., 2006; 
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Gallagher & Knoblich, 2006). Despite the lack of a comprehensive knowledge of this system, 
the literature does support a role for Notch in development which could be pertinent to 
neuronal development in humans. 
Human CC2D1A has been shown to interact with the endocytic proteins, CHMP4B and 
CHMP4C (components of the ESCRT protein), potentially indicating a role for CC2D1A in 
endocytic trafficking pathways (Tsang, et al., 2006). Our preliminary work suggests that the 
phospholipid binding properties of CC2D1A mirror those of Lgd. Both proteins bind the 
monophosphorylated phosphatidyl inositides PI(3)P, PI(4)P, PI(5)P, while our work 
indicates that CC2D1A also appears to bind PA, and PI(3,4,5)P3 (PIP3), perhaps suggesting 
additional functions in humans (Millar, et al., 2011). In CC2D1A, lack of the C2 domain or 
incorporation of a point mutation in the fourth DM14 domain (analogous to that in Lgd, 
discussed above) disrupts the lipid binding properties, again, echoing the findings in D. 
melanogaster. Consistent with these findings, the CC2D1A NSMR-like truncation mutant 
(which lacks the fourth DM14 domain, C2 domain and HLH domain) displayed loss of 
phospholipid binding capacity. Further study is ongoing in our lab to clarify the 
contribution of other domains within CC2D1A that may be required for phospholipid 
binding. It remains to be systematically examined whether the lipid binding abilities of 
CC2D1A are related to Notch activity as seen in D. melanogaster. If human CC2D1A 
regulates Notch as Lgd appears to, it is possible that mutations in CC2D1A result in 
perturbations in endosomal trafficking thereby altering Notch signaling, leading to the 
dysregulated neural development, which in turn may contribute to the pathogenesis of 
NSMR.  
4. CC2D1A and Akt function 
Akt is a serine threonine kinase, and three mammalian isoforms have been identified (Akt1, 
Akt2, Akt3), each possessing a pleckstrin homology (PH) domain, kinase domain and 
regulatory domain. Activation of Akt first requires stimulation by one of a number of 
upstream components, the most characterized of which is PI3K. When PI3K is recruited to 
the plasma membrane, it binds activated tyrosine kinases or G-protein coupled receptors. In 
response to growth factors, cytokines or receptors, activated PI3K phosphorylates the 
membrane phospholipid PIP2. The resultant PIP3 accumulates on the plasma membrane 
and Akt binds PIP3 and is thus recruited to the plasma membrane, which enables PDK1 
phosphorylation of Akt at Thr308. Maximal Akt activation is achieved via additional (mTor-
mediated) phosphorylation of Akt at Ser473. Akt is then directed to the nucleus where it 
directs a wide array of functions including cell survival, metabolism, proliferation, and 
differentiation via its interaction with multiple different substrates (Manning & Cantley, 
2007). Akt targets include NF-κB (Kane, et al., 1999; Ozes, et al., 1999; Romashkova & 
Makarov, 1999), the proapoptotic protein BAD (del Peso et al, 1997; Luo et al., 2003), nitric 
oxide synthase (Dimmeler, et al., 1999; Fulton, et al., 1999; Michell, et al., 1999), glycogen 
synthase kinase 3beta (Cross, et al., 1995). 
Precise control of cortical development is required to generate structurally and functionally 
integrated neuronal networks and this requires correct orchestration of neuronal 
proliferation, migration, and differentiation (Chan, et al., 2002). The PI3K/Akt pathway has 
long been identified as a key regulator of cell survival and cell death, both developmentally 
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and in the adult. Akt both directly and indirectly modulates apoptosis, one strategy by 
which projections are eliminated during development by directing the death of neurons that 
fail to make appropriate connections in the developing brain (Raff, et al., 1993). It does so by 
phosphorylating proteins or phosphorylating transcription factors that promote survival 
(Brunet, et al., 1999; Datta, et al., 1997; Qi, et al., 2006; Zhou, et al., 2001). Multiple sources 
suggest the involvement of the PI3K/Akt pathway as a critical developmental control in 
neurogenesis (Easton, et al., 2005; Kwon, et al., 2001; Peng, et al., 2004) and dendritogenesis 
(Jaworski, et al., 2005; Kumar, et al., 2005; Read & Gorman, 2009). Akt has also been 
implicated in synaptogenesis (Akama & McEwen, 2003) and synaptic transmission (Wang, 
et al., 2003). Others have found the pathway to be essential for elongation, guidance and 
branching of both axons and dendrites (Cosker, et al., 2008; Luikart, et al., 2008). These 
findings are consistent with the widespread distribution of Akt in the central nervous 
system. Implication of PI3K/Akt signaling in development is further supported by findings 
that disrupted PI3K via PTEN (an inhibitor of the PI3K/Akt pathway) antagonism leads to 
reduced neuronal proliferation (Groszer, et al., 2001) and the fact that Akt3 (the most 
common neuronal isoform) null mice exhibit decreased brain size and weight (Chin & 
Toker, 2009; Tschopp, et al., 2005). Furthermore, Pten mutant mice have macrocephaly 
abnormal dendritic/axonal growth and synapse number and display social and behavioural 
deficits similar to that seen in autism (Chang, et al., 2007). Collectively, PI3K, Akt and mTor 
regulate Reelin’s effect on growth and branching of hippocampal dendrites (Jossin & 
Goffinet, 2007). In addition, altered Akt signaling has been implicated in common 
neurodevelopmental disorders, schizophrenia (Emamian, et al., 2004), and autism spectrum 
disorder (Levitt & Campbell, 2009; Wiznitzer, 2004). Thus substantial evidence supports the 
developmental importance of Akt signaling as well as in cognitive function in the adult.  
Given that Akt signalling is a developmentally significant pathway, it is of interest that it 
has been shown to be regulated by CC2D1A (Nakamura, et al., 2008). As mentioned, 
CC2D1A is localized to both the cytoplasm and the nucleus (Rogaeva & Albert, 2007), thus it 
is reasonable to presume that its location within the cell determines its primary function, 
with nuclear localization being pertinent to transcriptional regulation and cytoplasmic 
localization relating to Akt-mediated cell survival. The importance of scaffold proteins in 
achieving signaling specificity has been highlighted, especially since in the Akt pathway, 
PDK1 is thought to be constitutively active and scaffolding provides a means of regulating 
PDK1 and by extension, Akt activity (Nakamura, et al., 2008). As a scaffold protein, 
CC2D1A promoted an EGFR-induced Akt/PDK1 interaction resulting in Akt activation and 
a subsequent increase in cell survival. In particular, overexpression of CC2D1A resulted in 
formation of the PDK1/Akt complex which upregulated Akt activity, while silencing of 
CC2D1A decreased Akt activity and increased apoptosis. EGF receptor stimulation was 
necessary to induce Akt activation and the receptor itself was incorporated in the 
CC2D1A/PDK1/Akt complex. CC2D1A knockdown did not affect the PI3K product, PIP3, 
but a PI3K inhibitor curbed the CC2D1A/Akt interaction, with no change in the 
CC2D1A/PDK1 interaction. CC2D1A increased the rate of PDK1-mediated phosphorylation 
and activation of Akt in the presence of PIP3. Our work has indicated that CC2D1A binds 
PIP3, thus it is possible that the increased rate of Akt activation may be dependent on the 
lipid binding properties of CC2D1A. Consistent with this, it was revealed that CC2D1A 
function required the presence of the fourth DM14 domain, as ablating this domain 
abrogated the interaction between CC2D1A and Akt/PDK1 (Nakamura, et al., 2008). This 
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requirement for the fourth DM14 domain is significant given that a point mutant in this 
domain abrogated lipid binding (Millar, et al., 2011) and it is clinically relevant as the 
domain is absent in the CC2D1A mutation present in NSMR. These findings imply that 
CC2D1A lipid binding regulates multiple signaling pathways and suggest a possible 
developmental need for the fourth DM14 domain in Akt signaling, endocytosis and Notch 
signaling which may relate to NSMR pathogenesis. With respect to Akt signaling, further 
support for the involvement of Akt function in NSMR comes from the findings that Akt has 
been implicated in developmental disorders, CNS development, learning and memory, 
which it general, allude to a potential role for CC2D1A in brain development and cognitive 
function via its regulation of the cell survival promoting Akt signalling cascade.   
5. CC2D1A-mediated NF-κB activation 
Nuclear factor kappa enhancer binding protein (NF-κB) refers to a well characterized, 
evolutionarily conserved family of transcription factors which regulate multiple genes 
involved in cell survival, development, ischemia and immune response (Hayden & Ghosh, 
2008). Five mammalian subunits of NF-κB have been identified (RelA, RelB, cRel, p50, p52), 
with these subunits forming homo- or heterodimers to generate a functional transcription 
factor. The most prevalent subunits in neurons are p50 and p65 and it is subunit 
composition that determines whether the transcription factor activates or represses gene 
expression. Multiple ligands activate NF-κB in neurons, including but not limited to nerve 
growth factor (NGF) (Carter, et al., 1996; Maggirwar, et al., 1998), glutamate (Guerrini, et al., 
1995), Fas (Cheema, et al., 1999), tumor necrosis factor-α (Barger, et al., 1995) intracellular 
calcium (O'Neill & Kaltschmidt, 1997), neuropeptides (Frenkel, et al., 2002), as well as 
activation triggered by synaptic neurotransmission (Guerrini, et al., 1995). NF-κB exerts its 
effects via two distinct, but interacting pathways, termed the canonical and the non-
canonical pathways. In the canonical NF-κB pathway, activation is mediated by a NEMO 
(IKKγ)-dependent IKK which degrades IκB. NF-κB in its inactive state is sequestered in the 
cytoplasm by the inhibitor protein, IκB. Ligand binding triggers signal transduction from 
TRAF to TAK1 which phosphorylates IκB kinase (IKK), activating it. Once activated, IKK 
phosphorylates IκB, targeting it for ubiquination and degradation. NF-κB is then freed and 
translocates to the nucleus where it exerts its effects on the expression of multiple genes. 
While in the non-canonical pathway activation is NEMO-independent and requires the 
processing of subunits p100 and p105 to mature and active forms.  
NF-κB appears to be involved in brain development as it is active throughout development 
and some of the NF-κB ligands listed above are specific to the CNS. Disruption of NF-κB 
signaling has recently been noted in autosomal recessive MR (Philippe, et al., 2009), 
substantiating the developmental relevance of NF-κB functions in the brain. Furthermore, 
learning enhances the expression of genes containing NF-κB regulatory elements, 
supporting a role for NF-ΚB -mediated transcriptional regulation in cognitive function 
(Levenson, et al., 2004; O'Sullivan, et al., 2007). The presence of certain NF-κB subunits has 
been characterized as a determinant in regulating CNS development and in synaptic 
plasticity, learning and memory, specifically implicating the p50, RelA/p65 and cRel 
subunits (Ahn, et al., 2008; Kaltschmidt, et al., 2006; Meffert & Baltimore, 2005; O'Riordan, et 
al., 2006).  In addition, NF-κB subunit composition, particularly the p65:p50 heterodimer is 
activated by excitatory stimulation at hippocampal synapses (Kaltschmidt, et al., 1993; 
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Meffert, et al., 2003; Suzuki, et al., 1997), a region key to learning and memory. Additionally, 
p65 null mice have defective hippocampal-dependent (spatial) learning (Meffert, et al., 
2003), and display decreased dendrite spine formation and morphological abnormalities in 
the hippocampus (Boersma, et al., 2011). Knockout of the c-Rel subunit impaired contextual 
memory (Yeh, et al., 2002). Thus, there is evidence that NF-κB activity could underlie 
synaptic plasticity both during development and in the adult and it is possible that 
disruption of NF-κB-mediated processes during development and in the adult could 
contribute to the deficiencies evident in NSMR. 
 An initial report, screening for human genes that induced NF-κB signaling, identified 
CC2D1A as an activator of NF-κB. Overexpression of CC2D1A, followed by reporter assays 
indicated that it could activate NF-κB, albeit more weakly than other proteins that were 
characterized (Matsuda, et al., 2003). More recent work has corroborated this notion, as in 
vitro overexpression of CC2D1A resulted in a significant increase in NF-κB activation (Zhao, 
et al., 2010). Their work supports CC2D1A as a regulator in the canonical NF-κB pathway, as 
CC2D1A-mediated regulation of NF-κB activation required the presence of tumor necrosis 
factor receptor associated factor (TRAF2), the protein kinase TAK1, Ubc13 and the IκB 
kinase complex, all components of the canonical pathway. Subcellular localization of 
CC2D1A was determined to be primarily cytoplasmic, consistent with the location of 
inactive NF-κB. It remains unclear how or where within the NF-κB pathway that CC2D1A 
exerts its regulatory effects in this system, nor is it clear what signal triggers CC2D1A 
activity. However, the C2 domain is required to achieve NF-κB activation as deletion of this 
domain abrogated activation. Interestingly, a CC2D1A mutant resembling the truncation 
mutation in NSMR retained only ~30% NF-κB activation levels relative to the full length 
CC2D1A. Thus given the developmental role of NF-κB and its relationship to cognitive 
function, CC2D1A-mediated regulation of this pathway may also be implicated in the 
dysregulated brain development which may be one contributing factor in the development 
of MR. 
6. CC2D1A and centrosomal function 
The mitotic cell cycle is a process within which cell division occurs, generating two daughter 
cells, each containing the full complement of the genome. A critical regulator of this is the 
centrosome, also referred to as the microtubule organizing centre (MTOC). The centrosome 
provides the bipolar microtubule spindle structure along which the chromosomes align and 
regulates sister chromatid separation. Thus defects in this apparatus could interfere with 
normal mitotic cell division and normal development.  This is consistent with recent 
findings that centrosomal function has been implicated in human neural development and 
in particular, in microcephaly, which is accompanied by mental retardation. During the 
course of normal cortical development, the pool of progenitor cells expands, neurogenesis 
occurs, followed by neuronal migration and the formation of the cortical lamina. 
Interestingly, in mouse models with centrosomal abnormalities, there is a decrease in 
progenitor proliferation and neurogenesis occurs earlier, likely resulting in a decrease in the 
number of new neurons while migration is disrupted and the result is a dysplastic cortex. 
(Buchman, et al., 2010; Fish, et al., 2006; Lizarraga, et al., 2010; Manzini & Walsh, 2011; 
Pulvers, et al., 2010).  Aberrant cytoskeletal structure or function has been identified in 
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cortical malformations and six of the seven genes implicated in microcephaly code for 
proteins related to the microtubule organizing centre in the centrosome (Manzini & Walsh, 
2011). Mutations in NDE1 (Bakircioglu, et al., 2011), CDK5RAP2 (Lizarraga, et al., 2010), 
STIL (Kumar, et al., 2009), WDR62 (Bilguvar, et al., 2010; Nicholas, et al., 2010; Yu, et al., 
2010), ASPM, CENPJ, and CEP152 (Thornton & Woods, 2009), all proteins with known or 
suspected involvement in centrosome function, have been identified in individuals with 
mental retardation (Manzini & Walsh, 2011).  
CC2D1A, together with cohesin, was shown to be required for normal centrosomal function 
(Nakamura, et al., 2009). CC2D1A localized to the centrosomes during interphase and 
mitosis and regulated centriole cohesion. siRNA targeted to CC2D1A resulted in multipolar 
spindles, misaligned chromosomes, cells arrested at the spindle checkpoint and resulted in 
fewer viable daughter cells. The C-terminal region of CC2D1A was shown to be required for 
centrosomal localization and the formation of bipolar spindles as full length, but not 
truncated CC2D1A rescued the multipolar spindle phenotype seen in cells depleted of 
CC2D1A.  Centriole splitting has been suggested to arise from premature activation of 
separase (Thein, et al., 2007), an enzyme responsible for sister chromatid separation and 
centriole disengagement by cleaving the Scc1 subunit of cohesin (Thein, et al., 2007; 
Uhlmann, et al., 1999; Waizenegger, et al., 2000). Thus cells were treated with siRNA against 
separase and this was found to suppress the formation of multipolar spindles seen with 
CC2D1A depletion (Nakamura, et al., 2009).  Furthermore, CC2D1A forms a complex with 
SMC1, a subunit of cohesin, and depletion of Scc1 resulted in multipolar spindles and arrest 
at spindle checkpoint, mirroring the effects of CC2D1A depletion. As CC2D1A siRNA 
decreased the level of Scc1 in the centrosomal fraction, it is suggested that normally, 
CC2D1A recruits cohesin to the spindle poles. Further work indicated that CC2D1A is 
phosphorylated during mitosis by cyclin B1-Cdk1 at Ser208, without which levels of Scc1-
CC2D1A complex are reduced, implying that this phosphorylation event may be regulating 
centrosome function (Nakamura, et al., 2010). Thus if CC2D1A regulates centrosome 
function, and aberrant centrosome activity is implicated in improper neural development 
and mental retardation, it is possible that this is relevant to the generation of NSMR in the 
CC2D1A truncation mutation. 
CC2D1A may also affect centrosome function via its interaction with the ESCRT-III proteins 
CHMP4B and CHMP4C. ESCRT-III and VPS4 proteins are localized to the centrosomes, 
regulating both maintenance or proliferation and cell division at the midbodies during 
abscission (Carlton, et al., 2008; Lindas, et al., 2008; Morita, et al., 2007; Samson, et al., 2008). 
Cells lacking the ESCRT-III and VPS4 proteins displayed abnormalities in abscission, and 
unexpectedly, at earlier mitotic stages, with centrosome number, morphology and function 
being altered (Morita, et al., 2010). Given that human CC2D1A interacts with CHMP4B and 
CHMP4C, and that CC2D1A-targeted siRNA results in multipolar spindles, it is noteworthy 
that this same phenotype is evident in cells treated with siRNA to ESCRT-III/VPS4 proteins, 
specifically, CHMP1A, CHMP1B, CHMP2B, CHMP4B, CHMP4C, CHMP7, VPS4A, and 
VPS4B (Morita, et al., 2010). These cells additionally had greater numbers of centrosomes 
and spindles. Thus CHMP4B and CHMP4C may mediate the effects of CC2D1A in 
regulating centrosome function, although it is unclear if this is the case or what specific 
mechanisms underlie this effect.  
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In summary, it is possible that the truncation of CC2D1A seen in NSMR leads to the 
developmental dysregulation of: transcriptional repression of a multiple genes; Notch 
signalling; Akt activation; NF-κB-mediated regulation of transcription; and/or centrosome 
function (Figure 2). Jointly or independently, disruption of these functions may represent the 
molecular basis for the developmental defects in cognitive architecture and function detected 
in NSMR. As previously mentioned, a recent study has indicated that CC2D1A knockout is 
lethal upon birth in mice (Zhao, et al., 2011), suggesting the possibility that the domains 
remaining in the NSMR truncated protein do retain some function. While this knockout is 
relevant, it would be of substantial use to generate an animal model of the NSMR-like 
truncation mutant to dissect the involvement of these remaining domains and to identify 
whether this model could recapitulate some of the cognitive deficits in NSMR. Future studies 
to further characterize the molecular mechanisms underlying each of these functions are also 
necessary to clarify any contribution from each pathway in the pathogenesis of NSMR and to 
identify whether there is any interaction between these systems.  
 
Fig. 2. Schematic of CC2D1A functions.  
CC2D1A/Freud-1 (Fr-1) acts in the nucleus as a transcriptional repressor (A) and in the 
cytoplasm modulating Akt signaling (B), endosomal trafficking (C), cell cycle progression 
(D), and NF-κB activation (E). 
Furthermore, functional domain analysis of CC2D1A will yield insight into which domains 
are required for each function and the degree to which each of the currently identified 
CC2D1A functions are important in the development of NSMR. As indicated above, it is 
evident that the C2 domain, as well as the fourth DM14 domain, are integral to some of the 
functions discussed here. This is of interest given that these two domains are absent in the 
NSMR truncation and intimates that the NSMR phenotype may be due to the disruption of 
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cell survival and normative neuronal development that is perhaps attributable to the 
absence of these CC2D1A domains and the functions subsumed by each.  
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